Cesca Therapeutics (KOOL) Announces Positive SurgWerks Feasibility Study in CLI
Tweet Send to a Friend
Cesca Therapeutics Inc. (Nasdaq: KOOL) announced 40-month follow-up results for a number of patients that participated in the Company’s earlier ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
